requip 0.25 mg film-coated tablets
glaxosmithkline (ireland) limited - ropinirole hydrochloride - film-coated tablet - 0.25 milligram(s) - dopamine agonists; ropinirole
requip 0.5 milligram film coated tablet
glaxosmithkline (ireland) limited - ropinirole hydrochloride - film coated tablet - 0.5 milligram
requip 1 mg film-coated tablets
glaxosmithkline (ireland) limited - ropinirole hydrochloride - film-coated tablet - 1 milligram(s) - dopamine agonists; ropinirole
requip 2 mg film-coated tablets
glaxosmithkline (ireland) limited - ropinirole hydrochloride - film-coated tablet - 2 milligram(s) - dopamine agonists; ropinirole
requip 5mg tablets
glaxosmithkline uk ltd - ropinirole hydrochloride - oral tablet - 5mg
requip 250microgram tablets
glaxosmithkline uk ltd - ropinirole hydrochloride - oral tablet - 250microgram
requip 2mg tablets
glaxosmithkline uk ltd - ropinirole hydrochloride - oral tablet - 2mg
daklinza 60 mg film-coated tablets
dksh malaysia sdn bhd - daclatasvir dihydrochloride -
daklinza 30 mg film-coated tablets
dksh malaysia sdn bhd - daclatasvir dihydrochloride -
xanax x.r. 0.5 mg
pfizer pfe pharmaceuticals israel ltd - alprazolam - tablets sustained release - alprazolam 0.5 mg - alprazolam - for the treatment of anxiety and anxiety associated with depression.treatment of panic disorder with or without phobic avoidance